In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 4-(2-aminoethyl)benzene-1,2-diol hydrochloride Drug Master File in Korea (4-(2-aminoethyl)benzene-1,2-diol hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 4-(2-aminoethyl)benzene-1,2-diol hydrochloride. The MFDS reviews the 4-(2-aminoethyl)benzene-1,2-diol hydrochloride KDMF as part of the drug registration process and uses the information provided in the 4-(2-aminoethyl)benzene-1,2-diol hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a 4-(2-aminoethyl)benzene-1,2-diol hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 4-(2-aminoethyl)benzene-1,2-diol hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 4-(2-aminoethyl)benzene-1,2-diol hydrochloride suppliers with KDMF on PharmaCompass.